Skip to content
AlternativeMed
Meditation cushion and folded blanket beside a sunlit window with a green houseplant

THERAPIES & TRADITIONS · COMPARED

Meditation Compared With Medication and Therapy: Trial Evidence

Head-to-head trial evidence comparing mindfulness programs with antidepressants and with CBT for anxiety, depression relapse, OCD and grief, with limits and why you should never stop medicine alone.

Content last updated . This page has not been medically reviewed.

Back to Meditation and Mindfulness

Urgent help and one rule

If you or someone else is in danger, call 911 in the US; for emotional crisis, call or text 988 (free, 24 hours a day). [1] Do not stop or lower a prescribed medicine because of what you read here. Talk with your prescriber first. NCCIH advises against using meditation to replace conventional care. [2]

The short answer

In well-run trials, structured mindfulness programs (such as MBSR and MBCT) often performed about as well as established treatments for some conditions, and worse for others. They have rarely been shown to be better. A major JAMA review found no evidence that meditation programs beat any active treatment, including drugs, exercise or other behavioral therapies. [3] A larger review across psychiatric conditions found mindfulness-based programs did not differ from evidence-based treatments overall. [4]

Trial evidence by comparison

Labels: promising but limited, mixed.
Condition and comparisonWhat the trial or review foundLabel and caveats
Anxiety disorders: MBSR vs the antidepressant escitalopram, 8 weeks, 276 US adultsMBSR was noninferior on clinician-rated severity (difference -0.07, interval -0.38 to 0.23). Study-related side effects occurred in 15% on MBSR and 79% on escitalopram, and 8% stopped escitalopram for side effects. [5]Promising but limited. Short follow-up; people knew their treatment.
Recurrent depression, relapse: MBCT with support to taper medicine vs staying on antidepressants, 424 UK patients, 24 monthsNo difference in time to relapse (hazard ratio 0.89, interval 0.67 to 1.18). [6]Promising but limited. Not shown to be better.
Same question, adding MBCT to antidepressants, 68 Dutch patientsMBCT did not further cut relapse. [7]Small trial; patients tended to prefer staying on medicine.
Depression relapse, pooled patient data from 9 trialsMBCT lowered relapse risk compared with usual care (hazard ratio 0.69) and with active treatments including antidepressants (0.79). [8]Mixed to promising: stronger against usual care than against active treatments; benefit was largest for people with more residual symptoms.
Current depression: mindfulness vs CBT, 30 trials (2,750 people)Statistically equivalent. [9]Mixed: it is unclear whether similar results come from different mechanisms or shared factors.
Anxiety symptoms: mindfulness vs CBT, 11 trialsNo overall difference; CBT had a small edge on social anxiety scales. [10]Small trials.
OCD: mindfulness vs CBT and exposure therapyNo difference from CBT (9 comparisons); better than medication in 5 comparisons. [11]Promising but limited; few medication comparisons.
Prolonged grief: MBCT vs grief-focused CBT, 100 adultsCBT reduced grief symptoms more at 6 months. [12]One trial.
Alcohol and drug use disorders: mindfulness vs other treatmentMay slightly reduce days of use; abstinence and craving results uncertain. [13]Low or very low certainty.

How to read comparison trials

  • Equal does not mean best. A noninferiority trial asks whether a treatment is not meaningfully worse; it does not show it is better. [5]
  • Blinding. People cannot be blinded to meditation, so expectations may affect self-ratings; the anxiety trial used blinded clinical interviewers for its main outcome. [5]
  • Selection. People who agree to be randomized to mindfulness may differ from the general public; the Dutch relapse trial noted that its patients often preferred the certainty of medicine. [7]
  • Publication bias. Mindfulness trials report positive results more often than expected, so published comparisons may look rosier. [14]
  • Side effects of meditation exist too. About 8 percent of participants in a review of 83 studies reported a negative effect, most often anxiety or depression. [15]

What this means for choosing

Mindfulness can reasonably be an option alongside or instead of other evidence-based care for some conditions, chosen with a clinician, especially for people who dislike medicine side effects or want skills for relapse prevention. It can also be combined with other treatment. It should not be used as a reason to delay care, and decisions about medicine belong with your prescriber.

Related pages

Frequently asked questions

Is meditation as good as antidepressants?

For preventing relapse in recurrent depression, one large UK trial found no difference between MBCT with support to taper medicine and staying on antidepressants over 24 months. [6] It does not show meditation works for everyone, or that you should stop medicine on your own.

Is mindfulness as effective as CBT?

Across 30 head-to-head trials for current depression, the two were equivalent. [9] For prolonged grief, grief-focused CBT did better in one trial. [12]

Can mindfulness replace anxiety medicine?

In one 8-week trial, MBSR was noninferior to escitalopram for anxiety disorders. [5] Evidence is from a single large trial with short follow-up, so discuss any change with your prescriber.

Should I do both?

Adding MBCT to antidepressants did not further cut relapse in one small trial. [7] Many people use more than one approach; it is a decision to make with your clinician.

Why can reviews disagree?

They use different comparison groups, outcomes and quality rules. Comparisons with no treatment look better than comparisons with active treatment. [4]

References
  1. 988 Suicide & Crisis Lifeline. 988 Lifeline. Read 2026-10-22.
  2. NCCIH. Meditation and Mindfulness: What You Need To Know. Read 2026-10-22.
  3. JAMA internal medicine 2014. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis.. Abstract read 2026-10-22.
  4. Clinical psychology review 2018. Mindfulness-based interventions for psychiatric disorders: A systematic review and meta-analysis.. Abstract read 2026-10-22.
  5. JAMA psychiatry 2023. Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial.. Abstract read 2026-10-22.
  6. Lancet (London, England) 2015. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial.. Abstract read 2026-10-22.
  7. Journal of affective disorders 2015. Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial.. Abstract read 2026-10-22.
  8. JAMA psychiatry 2016. Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse: An Individual Patient Data Meta-analysis From Randomized Trials.. Abstract read 2026-10-22.
  9. Clinical psychology review 2023. Comparing the efficacy of mindfulness-based therapy and cognitive-behavioral therapy for depression in head-to-head randomized controlled trials: A systematic review and meta-analysis of equivalence.. Abstract read 2026-10-22.
  10. Annals of palliative medicine 2021. Mindfulness-based therapy versus cognitive behavioral therapy for people with anxiety symptoms: a systematic review and meta-analysis of random controlled trials.. Abstract read 2026-10-22.
  11. Journal of anxiety disorders 2025. Mindfulness- and acceptance-based programmes for obsessive-compulsive disorder: A systematic review and meta-analysis.. Abstract read 2026-10-22.
  12. JAMA psychiatry 2024. Cognitive Behavior Therapy vs Mindfulness in Treatment of Prolonged Grief Disorder: A Randomized Clinical Trial.. Abstract read 2026-10-22.
  13. The Cochrane database of systematic reviews 2021. Mindfulness-based interventions for substance use disorders.. Abstract read 2026-10-22.
  14. PloS one 2016. Reporting of Positive Results in Randomized Controlled Trials of Mindfulness-Based Mental Health Interventions.. Abstract read 2026-10-22.
  15. Acta psychiatrica Scandinavica 2020. Adverse events in meditation practices and meditation-based therapies: a systematic review.. Abstract read 2026-10-22.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.